Verrica Pharmaceuticals buy Needham & Company LLC
Start price
14.05.24
/
50%
€9.90
Target price
14.05.25
€14.81
Performance (%)
-26.82%
Price
19.07.24
€6.73
Summary
This prediction is currently active. The price of Verrica Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.82%. This prediction currently runs until 14.05.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Verrica Pharmaceuticals | -13.282% | -13.282% |
iShares Core DAX® | -3.033% | -0.013% |
iShares Nasdaq 100 | -3.554% | -2.546% |
iShares Nikkei 225® | -3.938% | 2.183% |
iShares S&P 500 | -1.517% | -0.882% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target raised by analysts at Needham & Company LLC from $8.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for VRCA provided by MarketBeat
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.74
10.11.23
10.11.23
€7.49
10.11.24
10.11.24
145.44%
19.07.24
19.07.24
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€3.90
23.08.23
23.08.23
€9.25
23.08.24
23.08.24
85.77%
19.07.24
19.07.24